What does a biopsy involve when checking for SCC? 

A skin biopsy is a routine clinical procedure used by healthcare professionals in the United Kingdom to confirm the presence of abnormal cells within a suspicious lesion. When a General Practitioner or a dermatologist identifies a growth that shows characteristics of squamous cell carcinoma, they require a definitive tissue sample to be examined under a microscope. This process is essential because many skin conditions can look similar to the naked eye, and a formal laboratory analysis is the only way to establish an accurate diagnosis and determine the best course of management. The procedure is typically performed in an outpatient setting, meaning most patients are able to return home shortly after the sample has been taken. 

What We’ll Discuss in This Article 

• The purpose of a diagnostic biopsy in skin cancer management 

• Preparation and the use of local anaesthetic for patient comfort 

• Different techniques including punch, shave, and incisional biopsies 

• Wound care and the immediate recovery process following the procedure 

• The role of the pathologist in analysing the skin sample 

• How biopsy results are communicated and used to plan treatment 

The clinical purpose of a skin biopsy 

A biopsy is primarily performed to provide a definitive diagnosis when a clinician suspects that a skin lesion might be a squamous cell carcinoma. While a specialist can often identify highly suspicious features using a dermatoscope, the physical removal of a tissue sample allows for a detailed microscopic examination of the individual cell structures. The National Health Service explains that a biopsy involves taking a small sample of skin so it can be tested in a laboratory to see if there are any cancer cells present. This test helps to determine not only if the growth is malignant but also the specific subtype and how deeply it has invaded the layers of the skin. 

By obtaining this information, the medical team can decide on the most appropriate surgical or non-surgical treatment pathway. A biopsy is often the first step in the faster diagnosis standard, which aims to provide patients with clarity regarding their symptoms within a set timeframe. It ensures that patients receive the correct level of care based on the biological behaviour of their specific lesion. Without a biopsy, it would be difficult to distinguish an invasive squamous cell carcinoma from a pre-cancerous actinic keratosis or a benign keratoacanthoma, which may require different clinical approaches. 

Preparation and the administration of local anaesthetic 

The biopsy procedure begins with a thorough cleaning of the skin area to reduce the risk of infection. The clinician will explain the steps involved and confirm that the patient is comfortable before proceeding. To ensure the process is painless, a local anaesthetic is injected into the skin immediately surrounding the suspicious lesion. This injection may cause a brief stinging sensation for a few seconds, but the area quickly becomes numb, ensuring that the patient feels no pain during the actual removal of the tissue sample. 

NICE clinical guidelines recommend that all diagnostic biopsies should be performed under local anaesthetic to ensure patient comfort and to allow for a precise sample to be taken. Once the anaesthetic has taken effect, the specialist will check the area to ensure it is completely numb. The patient remains awake throughout the process and can communicate with the medical team. This targeted approach to pain relief is highly effective and avoids the risks and recovery time associated with a general anaesthetic. After the procedure, the numbness will gradually wear off over a few hours, at which point the site might feel slightly tender. 

Common biopsy techniques for suspected SCC 

There are several different techniques that a clinician might use to take a skin sample, depending on the size and location of the lesion. A punch biopsy is a frequent choice, involving a small circular tool that removes a tiny cylinder of skin, much like a hole punch. This method provides a sample of all the skin layers, which is particularly useful for checking the depth of a potential squamous cell carcinoma. If the lesion is very superficial or located in a delicate area, a shave biopsy might be used, where the specialist gently removes the top layers of the skin with a small blade. 

In cases where a lesion is quite large or has poorly defined borders, an incisional biopsy may be performed. This involves using a scalpel to remove a small wedge of tissue from the most representative part of the growth. Occasionally, if the lesion is small and the suspicion of cancer is very high, the specialist may perform an excisional biopsy, where the entire growth is removed in one go. The choice of technique is tailored to provide the pathologist with the best possible sample for an accurate diagnosis while minimising the impact on the surrounding healthy tissue. 

Wound care and immediate post-procedure recovery 

Once the skin sample has been removed, the clinician will focus on closing the wound and ensuring it is protected. Depending on the size and type of biopsy, a few small stitches may be required to bring the edges of the skin together. For a shave biopsy, the wound is usually left to heal naturally under a dressing, similar to a graze. The medical team will apply a sterile dressing to the site and provide the patient with specific instructions on how to keep the area clean and dry for the first twenty-four to forty-eight hours. 

Patients are generally advised to avoid strenuous physical activity for a day or two to prevent any tension on the wound or the stitches. Most people can return to their normal daily routine almost immediately, provided the biopsy site is protected. If stitches were used, an appointment will be made for their removal, typically one to two weeks later, depending on the location of the biopsy. The healing process is usually straightforward, and while a small permanent scar will remain, these are often very discreet and fade significantly over the following months. 

The role of the pathologist and the laboratory analysis 

The skin sample is placed in a preservative solution and sent to a pathology laboratory, where it is prepared for detailed analysis. A consultant pathologist, who is a doctor specialising in the study of cells and tissues, examines the sample under a high-powered microscope. They look for specific cellular changes that indicate malignancy, such as irregular nuclei or an abnormal arrangement of the squamous cells. They also assess the degree of differentiation, which helps to predict how aggressively the cancer might behave. 

The pathologist provides a formal report that confirms the diagnosis and includes vital details about the thickness of the lesion and whether it appears to have been fully captured in the sample. This document is the cornerstone of clinical decision making in the United Kingdom. It allows the dermatology multidisciplinary team to discuss the case and agree on the most effective long term management plan. Because of the complex laboratory processes involved, it can take one to two weeks for the final results to be completed and sent back to the referring clinician. 

Communication of results and next steps 

The results of the biopsy are usually communicated to the patient during a follow up appointment or sometimes over the telephone by a specialist nurse or the General Practitioner. If the biopsy confirms a squamous cell carcinoma, the next step is typically to arrange for the formal removal of any remaining cancer cells. This is often done through a surgical excision, where a wider margin of healthy skin is removed around the original site to ensure a total cure. The information from the biopsy is essential for planning this surgery, as it tells the surgeon exactly how wide and deep they need to go. 

If the biopsy shows that the lesion is benign or a pre-cancerous condition, the specialist will provide advice on whether any further treatment is needed. In many cases, no more action is required other than regular self-monitoring of the skin. Regardless of the result, the biopsy provides a clear clinical answer that removes uncertainty for the patient. For those diagnosed with a malignancy, the biopsy is the vital first step in a treatment journey that has very high success rates when the cancer is caught and managed at an early stage. 

Conclusion 

A skin biopsy for suspected squamous cell carcinoma involves the removal of a small tissue sample under local anaesthetic for laboratory analysis. The procedure is quick, generally painless, and uses various techniques to ensure an accurate diagnosis by a consultant pathologist. Once the results are available, they are used to create a tailored treatment plan that prioritises a complete cure and the best possible cosmetic outcome for the patient. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.